Tiverton Asset Management’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q3
$1.06M Hold
7,550
0.04% 289
2019
Q2
$1.38M Buy
7,550
+27
+0.4% +$4.94K 0.05% 233
2019
Q1
$1.2M Buy
7,523
+1,323
+21% +$211K 0.05% 220
2018
Q4
$594K Sell
6,200
-306
-5% -$29.3K 0.04% 218
2018
Q3
$919K Buy
6,506
+5,044
+345% +$712K 0.05% 205
2018
Q2
$229K Buy
+1,462
New +$229K 0.01% 303